Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shaddharana DS is a traditional **Ayurvedic oral polyherbal medicine** manufactured by AVN Ayurveda Formulations and presented as a **double-strength** version of Shaddharana. It is based on a classical formulation attributed to Sushruta and described in Ayurvedic literature including *Sushruta Samhita* and *Bhaishajya Ratnavali*. The formulation contains multiple herbal ingredients, including chitraka, indrayava, patha, katuka, ativisha, and abhaya, and is marketed for disorders involving digestion, inflammation, neuromuscular symptoms, and metabolic conditions described in Ayurvedic practice such as vata diabetes, grahani, piles, ascites, gout, and rheumatoid arthritis or joint pain. Its therapeutic rationale is rooted in traditional Ayurvedic principles rather than a validated single molecular target or conventional modern pharmacologic mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shaddharana DS.